These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18594826)

  • 21. Comprehensive Evaluation of Prostate Specific Membrane Antigen Expression in the Vasculature of Renal Tumors: Implications for Imaging Studies and Prognostic Role.
    Spatz S; Tolkach Y; Jung K; Stephan C; Busch J; Ralla B; Rabien A; Feldmann G; Brossart P; Bundschuh RA; Ahmadzadehfar H; Essler M; Toma M; Müller SC; Ellinger J; Hauser S; Kristiansen G
    J Urol; 2018 Feb; 199(2):370-377. PubMed ID: 28827104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of CD44, platelet-derived growth factor receptor alpha, and cyclooxygenase 2 expression in renal cell carcinoma.
    Tawfik OW; Kramer B; Shideler B; Danley M; Kimler BF; Holzbeierlein J
    Arch Pathol Lab Med; 2007 Feb; 131(2):261-7. PubMed ID: 17284111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD44 is an independent prognostic factor in conventional renal cell carcinomas.
    Paradis V; Ferlicot S; Ghannam E; Zeimoura L; Blanchet P; Eschwége P; Jardin A; Benoît G; Bedossa P
    J Urol; 1999 Jun; 161(6):1984-7. PubMed ID: 10332486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased expression of mucin 18 is associated with unfavorable postoperative prognosis in patients with clear cell renal cell carcinoma.
    Bai Q; Liu L; Long Q; Xia Y; Wang J; Xu J; Guo J
    Int J Clin Exp Pathol; 2015; 8(9):11005-14. PubMed ID: 26617818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.
    Pan D; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
    Jpn J Clin Oncol; 2015 Feb; 45(2):202-9. PubMed ID: 25420690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of CIP2A in clear cell renal cell carcinoma promotes cellular epithelial-mesenchymal transition and is associated with poor prognosis.
    Tang Q; Wang Q; Zeng G; Li Q; Jiang T; Zhang Z; Zheng W; Wang K
    Oncol Rep; 2015 Nov; 34(5):2515-22. PubMed ID: 26327467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear expression of Smad proteins and its prognostic significance in clear cell renal cell carcinoma.
    Park JH; Lee C; Suh JH; Chae JY; Moon KC
    Hum Pathol; 2013 Oct; 44(10):2047-54. PubMed ID: 23668999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma.
    Mou Y; Wu J; Zhang Y; Abdihamid O; Duan C; Li B
    BMC Cancer; 2021 Jan; 21(1):18. PubMed ID: 33402128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of adipose differentiation-related protein: a predictor of cancer-specific survival in clear cell renal carcinoma.
    Yao M; Huang Y; Shioi K; Hattori K; Murakami T; Nakaigawa N; Kishida T; Nagashima Y; Kubota Y
    Clin Cancer Res; 2007 Jan; 13(1):152-60. PubMed ID: 17200350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of dystroglycan correlates with tumor grade and predicts survival in renal cell carcinoma.
    Sgambato A; Camerini A; Amoroso D; Genovese G; De Luca F; Cecchi M; Migaldi M; Rettino A; Valsuani C; Tartarelli G; Donati S; Siclari O; Rossi G; Cittadini A
    Cancer Biol Ther; 2007 Dec; 6(12):1840-6. PubMed ID: 18087214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Non-metastatic clear cell renal carcinoma: prognostic significance of morphometric and biomolecular factors].
    Iurin AG
    Vopr Onkol; 2009; 55(2):177-82. PubMed ID: 19514371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of E-Cadherin and β-Catenin as Prognostic Factor in Renal Cell Carcinoma with Tumor Thrombus of the Vena Cava.
    Spachmann PJ; Breyer J; Kalogirou C; Lausenmeyer EM; Weber F; Prohaska S; Denzinger S; Burger M; Kübler H; Otto W; Vergho D
    Urol Int; 2019; 102(4):413-420. PubMed ID: 30844790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas.
    Fritzsche FR; Oelrich B; Johannsen M; Kristiansen I; Moch H; Jung K; Kristiansen G
    Clin Cancer Res; 2008 Nov; 14(21):7035-42. PubMed ID: 18981000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low CCL-21 expression associates with unfavorable postoperative prognosis of patients with metastatic renal cell carcinoma.
    Xiong Y; Liu L; Wang J; Xi W; Xia Y; Bai Q; Qu Y; Long Q; Xu J; Guo J
    Oncotarget; 2017 Apr; 8(15):25650-25659. PubMed ID: 27783999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low CCL17 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma.
    Xiong Y; Liu L; Xia Y; Wang J; Xi W; Bai Q; Qu Y; Xu J; Guo J
    BMC Cancer; 2017 Feb; 17(1):117. PubMed ID: 28178948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of TMEM27 expression is associated with postoperative progression of clinically localized conventional renal cell carcinoma.
    Javorhazy A; Farkas N; Beothe T; Pusztai C; Szanto A; Kovacs G
    J Cancer Res Clin Oncol; 2016 Sep; 142(9):1947-53. PubMed ID: 27417314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis.
    Mignogna C; Staibano S; Altieri V; De Rosa G; Pannone G; Santoro A; Zamparese R; D'Armiento M; Rocchetti R; Mezza E; Nasti M; Strazzullo V; Montanaro V; Mascolo M; Bufo P
    BMC Cancer; 2006 Dec; 6():293. PubMed ID: 17177989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma.
    Rioux-Leclercq N; Epstein JI; Bansard JY; Turlin B; Patard JJ; Manunta A; Chan T; Ramee MP; Lobel B; Moulinoux JP
    Hum Pathol; 2001 Nov; 32(11):1209-15. PubMed ID: 11727260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.